The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Gureeva M.A.
Patrice Lumumba Peoples’ Friendship University of Russia;
Moscow Regional Research and Clinical Institute
Molochkov A.V.
Patrice Lumumba Peoples’ Friendship University of Russia;
Moscow Regional Research and Clinical Institute
Polesko I.V.
The Russian National Research Medical University named after N.I. Pirogov
Molochkov V.A.
M.F. Vladimirsky Moscow Regional Research and Clinical Institute
Guseva T.S.
Gamaleya Federal Research Centre of Epidemiology and Microbiology
Effectiveness of recombinant interferon alpha in prevention of candida infection in patients at risk
Journal: Russian Journal of Clinical Dermatology and Venereology. 2024;23(4): 405‑414
Views: 632
Downloaded: 35
To cite this article:
Zlobin DE, Gureeva MA, Molochkov AV, et al. . Effectiveness of recombinant interferon alpha in prevention of candida infection in patients at risk. Russian Journal of Clinical Dermatology and Venereology.
2024;23(4):405‑414. (In Russ.)
https://doi.org/10.17116/klinderma202423041405
The article is devoted to the study of effectiveness of interferon alpha-2b with antioxidant (alpha tocopherol acetate and ascorbic acid) in the form of rectal suppositories in the prevention of mucous membrane infection development by fungi of Candida genus in patients at risk. Patients with a proven diagnosis of diabetes mellitus at unreached target levels of glycemia were considered as a risk group. The possibility of including interferon alpha-2b drugs in the course of preventive and rehabilitation procedures in patients with past candida infection or high risk of Candida spp. infection development is being discussed.
An increase in the number of cases of Candida spp. resistance to anti-mycotic drugs is of significant concern to the medical community. Type I interferons probably play an important role in protecting the host from Candida albicans, which highlights their potential importance in developing therapeutic strategies against fungal infections.
To assess the effect of using recombinant interferon alpha-2b with antioxidant (alpha tocopherol acetate and ascorbic acid) in the form of rectal suppositories on Candida spp. colonization in patients with risk factors of manifest candidiasis development.
A cross-sectional single-center study was performed in groups of patients diagnosed with diabetes mellitus at unreached target levels of glycemia (HbA1c more than 7%, but less than 9%). The main methods of research were following: clinical physical examination with assessment of the mucous membranes of oral cavity and genital organs, as well as quantitative analysis of Candida spp. Colonies in swabs obtained from the mucous membranes of oral cavity and genital cavities.
The study shows that the use of rectal suppositories based on recombinant interferon alpha-2b has an effect on Candida spp. Colonization in patients with risk factors of manifest candidiasis development.
The study results are consistent with the data of several authors on the effectiveness of interferon alpha regarding fungi of Candida genus and the possibility of using interferon drugs as prophylactic agents to prevent the development of manifest infection process.
Authors:
Gureeva M.A.
Patrice Lumumba Peoples’ Friendship University of Russia;
Moscow Regional Research and Clinical Institute
Molochkov A.V.
Patrice Lumumba Peoples’ Friendship University of Russia;
Moscow Regional Research and Clinical Institute
Polesko I.V.
The Russian National Research Medical University named after N.I. Pirogov
Molochkov V.A.
M.F. Vladimirsky Moscow Regional Research and Clinical Institute
Guseva T.S.
Gamaleya Federal Research Centre of Epidemiology and Microbiology
Received:
21.05.2024
Accepted:
07.06.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.